Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With

Updated 05/17/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the long-term protection against HBV infection in adult subjects, aged 18-40 years vaccinated with three or four doses of Engerix-B 20 to 30 years ago

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02901951
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 4
Start date	October 11, 2016
Completion date	May 1, 2017

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02991599` - Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients	Phase 4
	Completed	`NCT03316807` - Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults	Phase 4
	Not yet recruiting	`NCT03962816` - Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients	Phase 4
	Not yet recruiting	`NCT03962881` - Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population	Phase 4
	Not yet recruiting	`NCT03962803` - Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients	Phase 4
	Completed	`NCT02432430` - Comparison of Immunization Quality Improvement Dissemination Study	N/A
	Not yet recruiting	`NCT05099757` - The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students	Phase 4
	Completed	`NCT02963714` - Immunogenicity of Hepatitis B Vaccination in Hemodialysis Patients	Phase 4
	Recruiting	`NCT01590381` - Assessment of HBV Vaccine Immunity After 18 Years	N/A
	Completed	`NCT00519649` - Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.	Phase 4